Top

Published in:

01-08-2012 | Original Article

Behavioral Medicine Approaches to Chronic Obstructive Pulmonary Disease

Authors: Andreas von Leupoldt, Ph.D., Anja Fritzsche, Ph.D., Ana F. Trueba, M.A., Alicia E. Meuret, Ph.D., Thomas Ritz, Ph.D.

Published in: Annals of Behavioral Medicine | Issue 1/2012

Abstract

Background

Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory disease and associated with considerable individual and socioeconomic burden. Recent research started examining the role of psychosocial factors for course and management of the disease.

Purpose

This review provides an overview on recent findings on psychosocial factors and behavioral medicine approaches in COPD.

Results

Research has identified several important psychosocial factors and effective behavioral medicine interventions in COPD. However, there is considerable need for future research in this field.

Conclusions

Although beneficial effects of some behavioral medicine interventions have been demonstrated in COPD, future research efforts are necessary to study the effects of distinct components of these interventions, to thoroughly examine promising but yet not sufficiently proven interventions, and to develop new creative interventions.

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD. 2010; Available from: http://www.goldcopd.com.

Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk of developing chronic obstructive pulmonary disease: A longitudinal population study. Lancet. 2011 Sep 10;378(9795):991–6.PubMedCrossRef

Kaptein AA, Scharloo M, Fischer MJ, Snoei L, Hughes BM, Weinman J, et al. 50 years of psychological research on patients with COPD—road to ruin or highway to heaven? Respir Med. 2009 Jan;103(1):3–11.PubMedCrossRef

National Clinical Guideline Centre. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care. 2010; Available from: http://www.nice.org.uk/CG101.

O’Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: A roundtable. Proc Am Thorac Soc. 2007 Mai;4(2):145–68.PubMedCrossRef

American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: A consensus statement. Am. J. Respir. Crit. Care Med. 1999 Jan;159(1):321–40.

Carrieri-Kohlman V, Gormley JM, Eiser S, Demir-Deviren S, Nguyen H, Paul SM, et al. Dyspnea and the affective response during exercise training in obstructive pulmonary disease. Nurs Res. 2001 Juni;50(3):136–46.PubMedCrossRef

Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: Review and hypotheses. Respir Physiol Neurobiol. 2009 Mai 30;167(1):53–60.PubMedCrossRef

Meek PM, Lareau SC, Hu J. Are self-reports of breathing effort and breathing distress stable and valid measures among persons with asthma, persons with COPD, and healthy persons? Heart Lung. 2003 Okt;32(5):335–46.PubMedCrossRef

10.

von Leupoldt A, Dahme B. Differentiation between the sensory and affective dimension of dyspnea during resistive load breathing in normal subjects. Chest. 2005 Nov;128(5):3345–9.CrossRef

11.

Davenport PW, Vovk A. Cortical and subcortical central neural pathways in respiratory sensations. Respir Physiol Neurobiol. 2009 Mai 30;167(1):72–86.PubMedCrossRef

12.

Evans KC. Cortico-limbic circuitry and the airways: Insights from functional neuroimaging of respiratory afferents and efferents. Biol Psychol. 2010 Apr;84(1):13–25.PubMedCrossRef

13.

von Leupoldt A, Dahme B. Cortical substrates for the perception of dyspnea. Chest. 2005 Juli;128(1):345–54.CrossRef

14.

von Leupoldt A, Sommer T, Kegat S, Baumann HJ, Klose H, Dahme B, et al. The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala. Am. J. Respir. Crit. Care Med. 2008 Mai 1;177(9):1026–32.CrossRef

15.

von Leupoldt A, Sommer T, Kegat S, Eippert F, Baumann HJ, Klose H, et al. Down-regulation of insular cortex responses to dyspnea and pain in asthma. Am. J. Respir. Crit. Care Med. 2009 Aug 1;180(3):232–8.CrossRef

16.

Schön D, Rosenkranz M, Regelsberger J, Dahme B, Büchel C, von Leupoldt A. Reduced perception of dyspnea and pain after right insular cortex lesions. Am. J. Respir. Crit. Care Med. 2008 Dez 1;178(11):1173–9.PubMedCrossRef

17.

Peiffer C. Dyspnea and emotion: What can we learn from functional brain imaging? Am. J. Respir. Crit. Care Med. 2008 Mai 1;177(9):937–9.PubMedCrossRef

18.

von Leupoldt A, Taube K, Henkhus M, Dahme B, Magnussen H. The impact of affective states on the perception of dyspnea in patients with chronic obstructive pulmonary disease. Biol Psychol. 2010 Apr;84(1):129–34.CrossRef

19.

von Leupoldt A, Taube K, Schubert-Heukeshoven S, Magnussen H, Dahme B. Distractive auditory stimuli reduce the unpleasantness of dyspnea during exercise in patients with COPD. Chest. 2007 Nov;132(5):1506–12.CrossRef

20.

Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 2009 Mai;33(5):1165–85.PubMedCrossRef

21.

Chen JC, Mannino DM. Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 1999 März;5(2):93–9.PubMedCrossRef

22.

Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet. 2007 Sep 1;370(9589):741–50.PubMedCrossRef

23.

Menezes AMB, Perez-Padilla R, Jardim JRB, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): A prevalence study. Lancet. 2005 Nov 26;366(9500):1875–81.PubMedCrossRef

24.

Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006 Nov;3(11):e442.PubMedCrossRef

25.

National Heart, Lung, and Blood Institute. Morbidity and mortality chartbook on cardiovascular, lung and blood diseases. 2009;Available from: http://www.nhlbi.nih.gov/resources/docs/cht-book.htm

26.

O’Donnell DE, Hernandez P, Kaplan A, Aaron S, Bourbeau J, Marciniuk D, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2008 update—highlights for primary care. Can. Respir. J. 2008 Feb;15 Suppl A:1A–8A.

27.

Wedzicha JA, Seemungal TAR. COPD exacerbations: Defining their cause and prevention. Lancet. 2007 Sep 1;370(9589):786–96.PubMedCrossRef

28.

Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: Results from the TORCH study. Am. J. Respir. Crit. Care Med. 2008 Aug 15;178(4):332–8.PubMedCrossRef

29.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): A prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009 Okt 3;374(9696):1171–8.PubMedCrossRef

30.

Vogelmeier C, Buhl R, Criée CP, Gillissen A, Kardos P, Köhler D, et al. Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie. 2007 Mai;61(5):e1–40.PubMedCrossRef

31.

Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs. Chest. 2008 Okt;134(4 Suppl):43S–56S.PubMedCrossRef

32.

Kullowatz A, Kanniess F, Dahme B, Magnussen H, Ritz T. Association of depression and anxiety with health care use and quality of life in asthma patients. Respir Med. 2007 März;101(3):638–44.PubMedCrossRef

33.

Sandberg S, Järvenpää S, Penttinen A, Paton JY, McCann DC. Asthma exacerbations in children immediately following stressful life events: a Cox’s hierarchical regression. Thorax. 2004 Dez;59(12):1046–51.PubMedCrossRef

34.

Wright RJ. Perinatal stress and early life programming of lung structure and function. Biol Psychol. 2010 Apr;84(1):46–56.PubMedCrossRef

35.

Kullowatz A, Rosenfield D, Dahme B, Magnussen H, Kanniess F, Ritz T. Stress effects on lung function in asthma are mediated by changes in airway inflammation. Psychosom Med. 2008 Mai;70(4):468–75.PubMedCrossRef

36.

Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: Prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010 Dez;25(12):1209–21.PubMedCrossRef

37.

Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Reviews in Clinical Gerontology. 2000;10(02):193–202.CrossRef

38.

de Voogd JN, Wempe JB, Koëter GH, Postema K, van Sonderen E, Ranchor AV, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest. 2009 März;135(3):619–25.PubMedCrossRef

39.

Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, et al. Influence of anxiety on health outcomes in COPD. Thorax. 2010 März;65(3):229–34.PubMedCrossRef

40.

Giardino ND, Curtis JL, Andrei A-C, Fan VS, Benditt JO, Lyubkin M, et al. Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: A cross-sectional study. Respir. Res. 2010;11:29.PubMedCrossRef

41.

Laurin C, Labrecque M, Dupuis G, Bacon SL, Cartier A, Lavoie KL. Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations. Psychosom Med. 2009 Juli;71(6):667–74.PubMedCrossRef

42.

Ng T-P, Niti M, Tan W-C, Cao Z, Ong K-C, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: Effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch. Intern. Med. 2007 Jan 8;167(1):60–7.PubMedCrossRef

43.

Vögele C, von Leupoldt A. Mental disorders in chronic obstructive pulmonary disease (COPD). Respir Med. 2008 Mai;102(5):764–73.PubMedCrossRef

44.

von Leupoldt A, Taube K, Lehmann K, Fritzsche A, Magnussen H. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest. 2011 Sep;140(3):730–6.CrossRef

45.

Xu W, Collet J-P, Shapiro S, Lin Y, Yang T, Platt RW, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am. J. Respir. Crit. Care Med. 2008 Nov 1;178(9):913–20.PubMedCrossRef

46.

Quint JK, Baghai-Ravary R, Donaldson GC, Wedzicha JA. Relationship between depression and exacerbations in COPD. Eur. Respir. J. 2008 Juli;32(1):53–60.PubMedCrossRef

47.

Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, et al. Functional impairment in COPD patients: The impact of anxiety and depression. Psychosomatics. 2000 Dez;41(6):465–71.PubMedCrossRef

48.

Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005 Apr;127(4):1205–11.PubMedCrossRef

49.

Neuman A, Gunnbjörnsdottir M, Tunsäter A, Nyström L, Franklin KA, Norrman E, et al. Dyspnea in relation to symptoms of anxiety and depression: A prospective population study. Respir Med. 2006 Okt;100(10):1843–9.PubMedCrossRef

50.

Livermore N, Sharpe L, McKenzie D. Panic attacks and panic disorder in chronic obstructive pulmonary disease: A cognitive behavioral perspective. Respir Med. 2010 Sep;104(9):1246–53.PubMedCrossRef

51.

Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir. Res. 2011;12:3.PubMedCrossRef

52.

Spruit MA, Watkins ML, Edwards LD, Vestbo J, Calverley PMA, Pinto-Plata V, et al. Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort. Respir Med. 2010 Juni;104(6):849–57.PubMedCrossRef

53.

Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax. 2008 Sep;63(9):831–8.PubMedCrossRef

54.

Kaplan RM, Ries AL. Chronic obstructive pulmonary disease: Behavioural assessment and treatment. In: A. A.Kaptein, T. L.Creer (eds.) Respiratory Disorders and Behavioral Medicine. London: Martin Dunitz; 2002. p. 85–116.

55.

Grodner S, Prewitt LM, Jaworsk BA, Myers R, Kaplan RM, Ries AL. The impact of social support in pulmonary rehabilitation of patients with chronic obstructive pulmonary disease. Annals of Behavioral Medicine. 1996 Sep;18:139–45.CrossRef

56.

Wong AWM, Gan WQ, Burns J, Sin DD, van Eeden SF. Acute exacerbation of chronic obstructive pulmonary disease: Influence of social factors in determining length of hospital stay and readmission rates. Can. Respir. J. 2008 Okt;15(7):361–4.PubMed

57.

Haave E, Hyland M. Different short-term and longitudinal results on perceived health status for asthma and COPD patients after pulmonary rehabilitation. Patients living alone have the largest improvements in perceived quality of life. Chron Respir Dis. 2008;5(2):69–73.PubMedCrossRef

58.

Trappenburg JC, Troosters T, Spruit MA, Vandebrouck N, Decramer M, Gosselink R. Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2005 Sep;86(9):1788–92.PubMedCrossRef

59.

Kara Kaşikçi M, Alberto J. Family support, perceived self-efficacy and self-care behaviour of Turkish patients with chronic obstructive pulmonary disease. J Clin Nurs. 2007 Aug;16(8):1468–78.PubMedCrossRef

60.

Petersen S, Taube K, Lehmann K, Van den Bergh O, von Leupoldt A. Social comparison and anxious mood in pulmonary rehabilitation: The role of cognitive focus. Brit J Health Psychol. 2011; doi:10.1111/j.2044-8287.2011.02048.x.

61.

Kühl K, Schürmann W, Rief W. Mental disorders and quality of life in COPD patients and their spouses. Int J Chron Obstruct Pulmon Dis. 2008;3(4):727–36.PubMed

62.

Pinto RA, Holanda MA, Medeiros MMC, Mota RMS, Pereira EDB. Assessment of the burden of caregiving for patients with chronic obstructive pulmonary disease. Respir Med. 2007 Nov;101(11):2402–8.PubMedCrossRef

63.

Tønnesen P, Carrozzi L, Fagerström KO, Gratziou C, Jimenez-Ruiz C, Nardini S, et al. Smoking cessation in patients with respiratory diseases: A high priority, integral component of therapy. Eur. Respir. J. 2007 Feb;29(2):390–417.PubMedCrossRef

64.

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606–13.PubMedCrossRef

65.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Juni;67(6):361–70.PubMedCrossRef

66.

Jones PW, Price D, van der Molen T. Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:289–96.PubMedCrossRef

67.

ZuWallack RL, Haggerty MC, Jones P. Clinically meaningful outcomes in patients with chronic obstructive pulmonary disease. Am. J. Med. 2004 Dez 20;117 Suppl 12A:49S-59S.PubMed

68.

Lareau SC, Yawn BP. Improving adherence with inhaler therapy in COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:401–6.PubMedCrossRef

69.

Vestbo J, Anderson JA, Calverley PMA, Celli B, Ferguson GT, Jenkins C, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009 Nov;64(11):939–43.PubMedCrossRef

70.

Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2006 Juni 15;173(12):1390–413.PubMedCrossRef

71.

Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;(4):CD003793.

72.

Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007 Mai;131(5 Suppl):4S-42S.PubMedCrossRef

73.

Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;(10):CD005305.

74.

Beauchamp MK, Janaudis-Ferreira T, Goldstein RS, Brooks D. Optimal duration of pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease—a systematic review. Chron Respir Dis. 2011;8(2):129–40.PubMed

75.

Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005 März;127(3):809–17.PubMedCrossRef

76.

Waschki B, Kirsten A, Holz O, Müller K-C, Meyer T, Watz H, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: A prospective cohort study. Chest. 2011 Aug;140(2):331–42.PubMedCrossRef

77.

Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial. Lancet. 2000 Jan 29;355(9201):362–8.PubMedCrossRef

78.

Behnke M, Jörres RA, Kirsten D, Magnussen H. Clinical benefits of a combined hospital and home-based exercise programme over 18 months in patients with severe COPD. Monaldi Arch Chest Dis. 2003 März;59(1):44–51.PubMed

79.

du Moulin M, Taube K, Wegscheider K, Behnke M, van den Bussche H. Home-based exercise training as maintenance after outpatient pulmonary rehabilitation. Respiration. 2009;77(2):139–45.PubMedCrossRef

80.

Maltais F, Bourbeau J, Shapiro S, Lacasse Y, Perrault H, Baltzan M, et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: A randomized trial. Ann. Intern. Med. 2008 Dez 16;149(12):869–78.PubMed

81.

Harris M, Smith BJ, Veale A. Patient education programs—can they improve outcomes in COPD? Int J Chron Obstruct Pulmon Dis. 2008;3(1):109–12.PubMed

82.

Kaptein AA, Scharloo M, Fischer MJ, Snoei L, Cameron LD, Sont JK, et al. Illness perceptions and COPD: An emerging field for COPD patient management. J Asthma. 2008 Okt;45(8):625–9.PubMedCrossRef

83.

Effing T, Monninkhof EM, van der Valk PDLPM, van der Palen J, van Herwaarden CLA, Partidge MR, et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007;(4):CD002990.

84.

Peytremann-Bridevaux I, Staeger P, Bridevaux P-O, Ghali WA, Burnand B. Effectiveness of chronic obstructive pulmonary disease-management programs: Systematic review and meta-analysis. Am. J. Med. 2008 Mai;121(5):433–43.e4.PubMedCrossRef

85.

Nguyen HQ, Carrieri-Kohlman V, Rankin SH, Slaughter R, Stulbarg MS. Is Internet-based support for dyspnea self-management in patients with chronic obstructive pulmonary disease possible? Results of a pilot study. Heart Lung. 2005 Feb;34(1):51–62.PubMedCrossRef

86.

Nguyen HQ, Donesky-Cuenco D, Wolpin S, Reinke LF, Benditt JO, Paul SM, et al. Randomized controlled trial of an internet-based versus face-to-face dyspnea self-management program for patients with chronic obstructive pulmonary disease: Pilot study. J. Med. Internet Res. 2008;10(2):e9.PubMedCrossRef

87.

Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007 Feb 22;356(8):775–89.PubMedCrossRef

88.

Andreas S, Hering T, Mühlig S, Nowak D, Raupach T, Worth H. Smoking cessation in chronic obstructive pulmonary disease: An effective medical intervention. Dtsch Arztebl Int. 2009 Apr;106(16):276–82.PubMed

89.

Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994 Nov 16;272(19):1497–505.PubMedCrossRef

90.

Kanner RE, Connett JE, Williams DE, Buist AS. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: The Lung Health Study. Am. J. Med. 1999 Apr;106(4):410–6.PubMedCrossRef

91.

Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am. J. Respir. Crit. Care Med. 2000 Feb;161(2 Pt 1):381–90.PubMed

92.

Rigotti NA, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2007;(3):CD001837.

93.

Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005;(2):CD001007.

94.

van der Meer RM, Wagena EJ, Ostelo RWJG, Jacobs JE, van Schayck CP. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2003;(2):CD002999.

95.

Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G. Impact of inspiratory muscle training in patients with COPD: What is the evidence? Eur. Respir. J. 2011 Feb;37(2):416–25.PubMedCrossRef

96.

Lötters F, van Tol B, Kwakkel G, Gosselink R. Effects of controlled inspiratory muscle training in patients with COPD: A meta-analysis. Eur. Respir. J. 2002 Sep;20(3):570–6.PubMedCrossRef

97.

Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008;(2):CD005623.

98.

Gosselink R. Controlled breathing and dyspnea in patients with chronic obstructive pulmonary disease (COPD). J Rehabil Res Dev. 2003 Okt;40(5 Suppl 2):25–33.PubMedCrossRef

99.

Marciniuk D, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian Thoracic Society clinical practice guideline. Can. Respir. J. 2011 Apr;18(2):69–78.PubMed

100.

Bianchi R, Gigliotti F, Romagnoli I, Lanini B, Castellani C, Grazzini M, et al. Chest wall kinematics and breathlessness during pursed-lip breathing in patients with COPD. Chest. 2004 Feb;125(2):459–65.PubMedCrossRef

101.

Nield MA, Soo Hoo GW, Roper JM, Santiago S. Efficacy of pursed-lips breathing: A breathing pattern retraining strategy for dyspnea reduction. J Cardiopulm Rehabil Prev. 2007 Aug;27(4):237–44.PubMed

102.

Gigliotti F, Romagnoli I, Scano G. Breathing retraining and exercise conditioning in patients with chronic obstructive pulmonary disease (COPD): A physiological approach. Respir Med. 2003 März;97(3):197–204.PubMedCrossRef

103.

Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1996 März;153(3):961–6.PubMed

104.

Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am. Rev. Respir. Dis. 1989 Juni;139(6):1435–8.PubMed

105.

King DA, Cordova F, Scharf SM. Nutritional aspects of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008 Mai 1;5(4):519–23.PubMedCrossRef

106.

Fritzsche A, Clamor A, von Leupoldt A. Effects of medical and psychological treatment of depression in patients with COPD—a review. Respir Med. 2011 Okt;105(10):1422–33.PubMedCrossRef

107.

Brenes GA. Anxiety and chronic obstructive pulmonary disease: Prevalence, impact, and treatment. Psychosom Med. 2003 Dez;65(6):963–70.PubMedCrossRef

108.

Butler AC, Beck A. Cognitive therapy for depression. The Clinical Psychologist. 1995;48(3):3–5.

109.

Ingram RE. The International Encyclopedia of Depression. New York: Springer; 2009.

110.

Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol. 1998 Mai;17(3):232–40.PubMedCrossRef

111.

Kunik ME, Braun U, Stanley MA, Wristers K, Molinari V, Stoebner D, et al. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med. 2001 Mai;31(4):717–23.PubMedCrossRef

112.

Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: A randomized controlled trial. Psychol Med. 2008 März;38(3):385–96.PubMedCrossRef

113.

Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clin Psychol Rev. 2006 Jan;26(1):17–31.PubMedCrossRef

114.

Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord. 2005 Sep;88(1):27–45.PubMedCrossRef

115.

Stewart RE, Chambless DL. Cognitive-behavioral therapy for adult anxiety disorders in clinical practice: A meta-analysis of effectiveness studies. J Consult Clin Psychol. 2009 Aug;77(4):595–606.PubMedCrossRef

116.

Baraniak A, Sheffield D. The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: A systematic review and meta-analysis. Patient Educ Couns. 2011 Apr;83(1):29–36.PubMedCrossRef

117.

Hynninen MJ, Bjerke N, Pallesen S, Bakke PS, Nordhus IH. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med. 2010 Juli;104(7):986–94.PubMedCrossRef

118.

Livermore N, Sharpe L, McKenzie D. Prevention of panic attacks and panic disorder in COPD. Eur. Respir. J. 2010 März;35(3):557–63.PubMedCrossRef

119.

Lehrer PM, Hochron SM, Mayne TM, Isenberg S, Lasoski AM, Carlson V, et al. Relationship between changes in EMG and respiratory sinus arrhythmia in a study of relaxation therapy for asthma. Appl Psychophysiol Biofeedback. 1997 Sep;22(3):183–91.PubMedCrossRef

120.

Ritz T. Relaxation therapy in adult asthma. Is there new evidence for its effectiveness? Behav Modif. 2001 Sep;25(4):640–66.PubMedCrossRef

121.

Jorm AF, Morgan AJ, Hetrick SE. Relaxation for depression. Cochrane Database Syst Rev. 2008;(4):CD007142.

122.

Lehrer PM, Woolfolk RL, Sime WE. Principles and Practice of Stress Management, Third Edition. Third Edition. New York: Guilford; 2007.

123.

Donesky-Cuenco D, Nguyen HQ, Paul S, Carrieri-Kohlman V. Yoga therapy decreases dyspnea-related distress and improves functional performance in people with chronic obstructive pulmonary disease: A pilot study. J Altern Complement Med. 2009 März;15(3):225–34.PubMedCrossRef

124.

Estève F, Blanc-Gras N, Gallego J, Benchetrit G. The effects of breathing pattern training on ventilatory function in patients with COPD. Biofeedback Self Regul. 1996 Dez;21(4):311–21.PubMedCrossRef

125.

Reybrouck T, Wertelaers A, Bertrand P, Demedts M. Myofeedback training of the respiratory muscles in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 1987;7:18–22.

126.

Tiep BL, Burns M, Kao D, Madison R, Herrera J. Pursed lips breathing training using ear oximetry. Chest. 1986 Aug;90(2):218–21.PubMedCrossRef

127.

Giardino ND, Chan L, Borson S. Combined heart rate variability and pulse oximetry biofeedback for chronic obstructive pulmonary disease: Preliminary findings. Appl Psychophysiol Biofeedback. 2004 Juni;29(2):121–33.PubMedCrossRef

128.

Vaschillo E, Vaschillo B, Lehrer P. Heartbeat synchronizes with respiratory rhythm only under specific circumstances. Chest. 2004 Okt;126(4):1385–6.PubMedCrossRef

129.

Yasuma F, Hayano J-I. Respiratory sinus arrhythmia: Why does the heartbeat synchronize with respiratory rhythm? Chest. 2004 Feb;125(2):683–90.PubMedCrossRef

130.

Collins EG, Fehr L, Bammert C, O’Connell S, Laghi F, Hanson K, et al. Effect of ventilation-feedback training on endurance and perceived breathlessness during constant work-rate leg-cycle exercise in patients with COPD. J Rehabil Res Dev. 2003 Okt;40(5 Suppl 2):35–44.PubMedCrossRef

131.

Collins EG, Langbein WE, Fehr L, O’Connell S, Jelinek C, Hagarty E, et al. Can ventilation-feedback training augment exercise tolerance in patients with chronic obstructive pulmonary disease? Am. J. Respir. Crit. Care Med. 2008 Apr 15;177(8):844–52.PubMedCrossRef

132.

von Leupoldt A, Dahme B. Psychological aspects in the perception of dyspnea in obstructive pulmonary diseases. Respir Med. 2007 März;101(3):411–22.CrossRef

133.

von Leupoldt A, Seemann N, Gugleva T, Dahme B. Attentional distraction reduces the affective but not the sensory dimension of perceived dyspnea. Respir Med. 2007 Apr;101(4):839–44.CrossRef

134.

Davenport PW, Chan P-YS, Zhang W, Chou Y-L. Detection threshold for inspiratory resistive loads and respiratory-related evoked potentials. J. Appl. Physiol. 2007 Jan;102(1):276–85.PubMedCrossRef

135.

Webster KE, Colrain IM. The respiratory-related evoked potential: Effects of attention and occlusion duration. Psychophysiology. 2000 Mai;37(3):310–8.PubMedCrossRef

136.

Bauldoff GS, Hoffman LA, Zullo TG, Sciurba FC. Exercise maintenance following pulmonary rehabilitation: Effect of distractive stimuli. Chest. 2002 Sep;122(3):948–54.PubMedCrossRef

137.

Thornby MA, Haas F, Axen K. Effect of distractive auditory stimuli on exercise tolerance in patients with COPD. Chest. 1995 Mai;107(5):1213–7.PubMedCrossRef

138.

Bauldoff GS, Rittinger M, Nelson T, Doehrel J, Diaz PT. Feasibility of distractive auditory stimuli on upper extremity training in persons with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2005 Feb;25(1):50–5.PubMedCrossRef

139.

Brooks D, Sidani S, Graydon J, McBride S, Hall L, Weinacht K. Evaluating the effects of music on dyspnea during exercise in individuals with chronic obstructive pulmonary disease: A pilot study. Rehabil Nurs. 2003 Dez;28(6):192–6.PubMed

140.

Pfister T, Berrol C, Caplan C. Effects of music on exercise and perceived symptoms in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 1998 Juni;18(3):228–32.PubMedCrossRef

141.

Brutsche MH, Grossman P, Müller RE, Wiegand J, Pello, Baty F, et al. Impact of laughter on air trapping in severe chronic obstructive lung disease. Int J Chron Obstruct Pulmon Dis. 2008;3(1):185–92.PubMed

142.

Lebowitz KR, Suh S, Diaz PT, Emery CF. Effects of humor and laughter on psychological functioning, quality of life, health status, and pulmonary functioning among patients with chronic obstructive pulmonary disease: A preliminary investigation. Heart Lung. 2011 Aug;40(4):310–9.PubMedCrossRef

143.

Bonilha AG, Onofre F, Vieira ML, Prado MYA, Martinez JAB. Effects of singing classes on pulmonary function and quality of life of COPD patients. Int J Chron Obstruct Pulmon Dis. 2009;4:1–8.PubMed

144.

Lord VM, Cave P, Hume VJ, Flude EJ, Evans A, Kelly JL, et al. Singing teaching as a therapy for chronic respiratory disease—a randomised controlled trial and qualitative evaluation. BMC Pulm Med. 2010;10:41.PubMedCrossRef

Title: Behavioral Medicine Approaches to Chronic Obstructive Pulmonary Disease
Authors: Andreas von Leupoldt, Ph.D.
Anja Fritzsche, Ph.D.
Ana F. Trueba, M.A.
Alicia E. Meuret, Ph.D.
Thomas Ritz, Ph.D.
Publication date: 01-08-2012
Publisher: Springer-Verlag
Published in: Annals of Behavioral Medicine / Issue 1/2012
Print ISSN: 0883-6612
Electronic ISSN: 1532-4796
DOI: https://doi.org/10.1007/s12160-012-9348-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Behavioral Medicine Approaches to Chronic Obstructive Pulmonary Disease

Abstract

Background

Purpose

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Purpose

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2012

Avoidance of Activities in Early Symptomatic Knee Osteoarthritis: Results from the CHECK Cohort

A Randomised Trial of a Weight Loss Intervention for Overweight and Obese People Diagnosed with Coronary Heart Disease and/or Type 2 Diabetes

Response to Debate on the Self-Report Habit Index

Associations Between Socioeconomic Status and Catecholamine Levels Vary by Acculturation Status in Mexican-American Women

Non-adherence to Immunosuppressive Medications in Kidney Transplantation: Intent Vs. Forgetfulness and Clinical Markers of Medication Intake

Does Affective Valence During and Immediately Following a 10-Min Walk Predict Concurrent and Future Physical Activity?